SEP 11 2026
Telix Pharmaceuticals Limited — Pixclara (TLX101-Px) $TLX
for brain cancer imaging
Accepted APR 10 2026.
for brain cancer imaging
Accepted APR 10 2026.
Pixclara is a radioactive imaging agent designed to target and illuminate brain cancer tissue. It delivers a radioactive tracer that binds to a specific target found on the surface of cancer cells. This allows doctors to visualize the location and extent of the disease, which could help guide more precise treatment decisions.